You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 292 No. 6, August 11, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (34)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Viral Infections
 •Immunization
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Contagiousness of Varicella in Vaccinated Cases

A Household Contact Study

Jane F. Seward, MBBS, MPH; John X. Zhang, PhD; Teresa J. Maupin, RN, MA; Laurene Mascola, MD, MPH; Aisha O. Jumaan, PhD, MPH

JAMA. 2004;292:704-708.

Context  Limited data are available on the contagiousness of vaccinated varicella cases.

Objectives  To describe secondary attack rates within households according to disease history and vaccination status of the primary case and household contacts and to estimate varicella vaccine effectiveness.

Design, Setting, and Patients  Population-based, active varicella surveillance project in a community of approximately 320 000 in Los Angeles County, California, during 1997 and 2001. Varicella cases were reported by child care centers, private and public schools, and health care clinicians and were investigated to collect demographic, clinical, medical, and vaccination data. Information on household contacts' age, varicella history, and vaccination status was collected.

Main Outcome Measures  Varicella secondary attack rate among household contacts; vaccine effectiveness using secondary attack rates in unvaccinated and vaccinated children and adolescents.

Results  A total of 6316 varicella cases were reported. Among children and adolescents aged 1 to 14 years, secondary attack rates varied according to age and by disease and vaccination status of the primary case and exposed household contacts. Among contacts aged 1 to 14 years exposed to unvaccinated cases, the secondary attack rate was 71.5% if they were unvaccinated and 15.1% if they were vaccinated (risk ratio [RR], 0.21; 95% confidence interval [CI], 0.15-0.30). Overall, vaccinated cases were half as contagious as unvaccinated cases. However, vaccinated cases with 50 lesions or more were similarly contagious as unvaccinated cases whereas those with fewer than 50 lesions were only one third as contagious (secondary attack rate, 23.4%; RR, 0.32 [95% CI, 0.19-0.53]). Vaccine effectiveness for prevention of all disease was 78.9% (95% CI, 69.7%-85.3%); moderate disease, 92% (50-500 lesions) and 100% (clinician visit); and severe disease, 100%.

Conclusions  Under conditions of intense exposure, varicella vaccine was highly effective in preventing moderate and severe disease and about 80% effective in preventing all disease. Breakthrough varicella cases in household settings were half as contagious as unvaccinated persons with varicella, although contagiousness varied with numbers of lesions.


Author Affiliations: Centers for Disease Control and Prevention, Atlanta, Ga (Drs Seward, Zhang, and Jumaan); and the Los Angeles County Department of Health Services, Los Angeles, Calif (Ms Maupin and Dr Mascola).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Validity of Reported Varicella History as a Marker for Varicella Zoster Virus Immunity Among Unvaccinated Children, Adolescents, and Young Adults in the Post-Vaccine Licensure Era
Perella et al.
Pediatrics 2009;123:e820-e828.
ABSTRACT | FULL TEXT  

Herpes Zoster (Shingles) and Postherpetic Neuralgia
Sampathkumar et al.
Mayo Clin Proc. 2009;84:274-280.
ABSTRACT | FULL TEXT  

Varicella Prevention in the United States: A Review of Successes and Challenges
Marin et al.
Pediatrics 2008;122:e744-e751.
ABSTRACT | FULL TEXT  

Vaccine-Era Varicella Epidemiology and Vaccine Effectiveness in a Public Elementary School Population, 2002-2007
Lee et al.
Pediatrics 2008;121:e1548-e1554.
ABSTRACT | FULL TEXT  

Varicella-Zoster Virus Infections
Gershon
Pediatr. Rev. 2008;29:5-11.
FULL TEXT  

Prevention of Varicella: Recommendations for Use of Varicella Vaccines in Children, Including a Recommendation for a Routine 2-Dose Varicella Immunization Schedule
Committee on Infectious Diseases
Pediatrics 2007;120:221-231.
ABSTRACT | FULL TEXT  

Growth hormone secretion and immunological function of a male patient with a homozygous STAT5b mutation
Walenkamp et al.
Eur J Endocrinol 2007;156:155-165.
ABSTRACT | FULL TEXT  

Physician Attitudes Regarding Breakthrough Varicella Disease and a Potential Second Dose of Varicella Vaccine
Davis et al.
Pediatrics 2007;119:258-264.
ABSTRACT | FULL TEXT  

One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
Lopez et al.
Pediatrics 2006;117:e1070-e1077.
ABSTRACT | FULL TEXT  

Recent Steroid Therapy Increases Severity of Varicella Infections in Children With Acute Lymphoblastic Leukemia
Hill et al.
Pediatrics 2005;116:e525-e529.
ABSTRACT | FULL TEXT  

Contagiousness of Varicella in Vaccinated Cases
Schiff
AAP Grand Rounds 2004;12:61-61.
FULL TEXT  

Varicella Vaccine Effective in Household Contacts
JWatch Emergency Med. 2004;2004:5-5.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.